Hester Bios

{
  "main_header": {
    "sid": 324228,
    "name": "Hester Bios",
    "stock_name": "Hester Bios",
    "full_name": "Hester Biosciences Ltd",
    "name_url": "stocks-analysis/hester-bios",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,289.95",
    "chg": -7.35,
    "chgp": "-0.32%",
    "dir": -1,
    "prev_price": "2,297.30",
    "mcapval": "1,917.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524669,
    "symbol": "HESTERBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE782E01017",
    "curr_date": "Sep 11, 03:30 PM",
    "curr_time": "19:04 PM",
    "last_traded_at": "Sep 11, 03:30 PM IST",
    "bse_nse_vol": "6.17 k",
    "exc_status": "Active",
    "traded_date": "Sep 11, 2026",
    "traded_date_str": "2026 09 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hester-bios-324228-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-4183194",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/HesterBioscienc_mojoScore_4183194.png",
        "date": "2026-09-05 10:10:16",
        "description": "Hester Biosciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 September 2026, providing investors with the latest insights into its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4172693",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/HesterBioscienc_technicaldot_4172693.png",
        "date": "2026-08-28 08:01:02",
        "description": "Hester Biosciences Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of late August 2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s technical indicators present a complex picture, with bullish signals on longer-term charts contrasting with bearish pressures on weekly momentum metrics. This analysis delves into the latest technical parameters, price movements, and comparative returns to provide a comprehensive view of the stock’s current market stance."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-4168490",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/HesterBioscienc_mojoScore_4168490.png",
        "date": "2026-08-25 10:11:15",
        "description": "Hester Biosciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 August 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-4153367",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/HesterBioscienc_mojoScore_4153367.png",
        "date": "2026-08-14 10:11:17",
        "description": "Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-4133414",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/HesterBioscienc_mojoScore_4133414.png",
        "date": "2026-08-03 10:11:08",
        "description": "Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 August 2026, providing investors with the most up-to-date insight into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Hester Biosciences Gains 4.97%: 3 Key Factors Driving the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-gains-497-3-key-factors-driving-the-weeks-volatility-4132140",
        "imagepath": "",
        "date": "2026-08-02 09:01:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> Stock surges 6.94% to Rs.2,528.50 on strong buying interest</p>\n                    <p><strong>30 Jul:</strong> Hits new 52-week high at Rs.2,669 before closing lower amid mixed quarterly results</p>\n                    <p><strong>31 Jul:</strong> Recovers modestly, closing at Rs.2,482.05 (+0.84%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,364.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.2,482.05</div><div class=\"stat-change positive\">+4.97%</div></div..."
      },
      {
        "title": "Are Hester Biosciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-hester-biosciences-ltd-latest-results-good-or-bad-4129039",
        "imagepath": "",
        "date": "2026-07-30 19:19:53",
        "description": "Hester Biosciences Ltd's latest financial results for Q1 FY27 present a complex picture of the company's performance. The net profit reported was ₹96.98 crores, reflecting a substantial year-on-year growth of 489.90%. However, this impressive profit figure is accompanied by a concerning decline in net sales, which totaled ₹77.24 crores, representing an 8.17% decrease compared to the same quarter last year. This decline raises questions about the company's revenue generation capabilities and potential market challenges.\n\nThe operating margin, excluding other income, stood at 29.48%, which shows a slight improvement from the previous year. This indicates that the company has managed to maintain its operating profitability despite the drop in sales, suggesting effective cost management. However, the sequential decline in sales of 22.84% from the previous quarter indicates potential operational challenges that ..."
      },
      {
        "title": "Hester Biosciences Q1 FY27: Exceptional Profit Surge Masks Revenue Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/hester-biosciences-q1-fy27-exceptional-profit-surge-masks-revenue-concerns-4129003",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/HesterBioscienc_quaterlyResult_4129003.png",
        "date": "2026-07-30 17:02:41",
        "description": "Hester Biosciences Ltd., one of India's pioneering animal healthcare companies, has reported a remarkable 489.90% year-on-year surge in consolidated net profit to ₹96.98 crores for Q1 FY27, driven by an extraordinary one-time gain that inflated pre-tax profit to ₹101.68 crores. However, the underlying operational picture reveals concerning trends, with net sales declining 8.17% year-on-year to ₹77.24 crores and falling 22.84% sequentially from Q4 FY26's ₹100.11 crores. The stock, currently trading at ₹2,461.35 with a market capitalisation of ₹2,137 crores, has declined 1.30% following the results announcement, reflecting investor scepticism about the sustainability of this profit performance."
      },
      {
        "title": "Hester Biosciences Ltd Reports Flat Quarterly Performance Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-reports-flat-quarterly-performance-amid-margin-pressures-4128901",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/HesterBioscienc_fintrenddot_4128901.png",
        "date": "2026-07-30 15:00:06",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended June 2026, signalling a notable shift from its previously positive growth trajectory. Despite robust profit after tax growth and strong return on capital employed, the company faces headwinds from declining sales and margin contraction, prompting a downgrade in its Mojo Grade from Hold to Sell."
      }
    ],
    "total": 5500,
    "sid": "324228",
    "stock_news_url": "https://www.marketsmojo.com/news/hester-biosciences-324228"
  },
  "announcements": [
    {
      "caption": "Shareholders Approval For Reclassification From Promoter And Promoter Group Category To Public Category Shareholders",
      "datetime": "04-Sep-2026",
      "details": "Shareholders approval for Reclassification of Mr. Ravin Gandhi and Ms. Bela Gandhi from Promoter and Promoter Group category to Public Category shareholders of the Company.",
      "source": "BSE"
    },
    {
      "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
      "datetime": "04-Sep-2026",
      "details": "Scrutinizers Report for Postal Ballot Process",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
      "datetime": "04-Sep-2026",
      "details": "Outcome proceedings and Voting Results of Postal Ballot Process for the Notice dated 30 July 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has declared <strong>110%</strong> dividend, ex-date: 14 Jul 26",
          "dt": "2026-07-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 27 Sep 12",
          "dt": "2012-09-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>2:5</strong> rights issue, ex-date: 29 May 06",
          "dt": "2006-05-29",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Hester Biosciences Ltd is Rated Sell

2026-09-05 10:10:16

Hester Biosciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 September 2026, providing investors with the latest insights into its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-08-28 08:01:02

Hester Biosciences Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of late August 2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s technical indicators present a complex picture, with bullish signals on longer-term charts contrasting with bearish pressures on weekly momentum metrics. This analysis delves into the latest technical parameters, price movements, and comparative returns to provide a comprehensive view of the stock’s current market stance.

Read full news article

Hester Biosciences Ltd is Rated Sell

2026-08-25 10:11:15

Hester Biosciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 August 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Hester Biosciences Ltd is Rated Sell

2026-08-14 10:11:17

Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Hester Biosciences Ltd is Rated Sell

2026-08-03 10:11:08

Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 August 2026, providing investors with the most up-to-date insight into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Hester Biosciences Gains 4.97%: 3 Key Factors Driving the Week’s Volatility

2026-08-02 09:01:08

Key Events This Week

27 Jul: Stock surges 6.94% to Rs.2,528.50 on strong buying interest

30 Jul: Hits new 52-week high at Rs.2,669 before closing lower amid mixed quarterly results

31 Jul: Recovers modestly, closing at Rs.2,482.05 (+0.84%)

Week Open

Rs.2,364.50

Week Close

Rs.2,482.05

+4.97%

Read full news article

Are Hester Biosciences Ltd latest results good or bad?

2026-07-30 19:19:53

Hester Biosciences Ltd's latest financial results for Q1 FY27 present a complex picture of the company's performance. The net profit reported was ₹96.98 crores, reflecting a substantial year-on-year growth of 489.90%. However, this impressive profit figure is accompanied by a concerning decline in net sales, which totaled ₹77.24 crores, representing an 8.17% decrease compared to the same quarter last year. This decline raises questions about the company's revenue generation capabilities and potential market challenges. The operating margin, excluding other income, stood at 29.48%, which shows a slight improvement from the previous year. This indicates that the company has managed to maintain its operating profitability despite the drop in sales, suggesting effective cost management. However, the sequential decline in sales of 22.84% from the previous quarter indicates potential operational challenges that ...

Read full news article

Hester Biosciences Q1 FY27: Exceptional Profit Surge Masks Revenue Concerns

2026-07-30 17:02:41

Hester Biosciences Ltd., one of India's pioneering animal healthcare companies, has reported a remarkable 489.90% year-on-year surge in consolidated net profit to ₹96.98 crores for Q1 FY27, driven by an extraordinary one-time gain that inflated pre-tax profit to ₹101.68 crores. However, the underlying operational picture reveals concerning trends, with net sales declining 8.17% year-on-year to ₹77.24 crores and falling 22.84% sequentially from Q4 FY26's ₹100.11 crores. The stock, currently trading at ₹2,461.35 with a market capitalisation of ₹2,137 crores, has declined 1.30% following the results announcement, reflecting investor scepticism about the sustainability of this profit performance.

Read full news article

Hester Biosciences Ltd Reports Flat Quarterly Performance Amid Margin Pressures

2026-07-30 15:00:06

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended June 2026, signalling a notable shift from its previously positive growth trajectory. Despite robust profit after tax growth and strong return on capital employed, the company faces headwinds from declining sales and margin contraction, prompting a downgrade in its Mojo Grade from Hold to Sell.

Read full news article

View All News